These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31984676)

  • 41. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
    Reichel C
    Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
    [No Abstract]   [Full Text] [Related]  

  • 42. Monitoring recombinant human erythropoietin abuse among athletes.
    Citartan M; Gopinath SCB; Chen Y; Lakshmipriya T; Tang TH
    Biosens Bioelectron; 2015 Jan; 63():86-98. PubMed ID: 25058943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of illicit glucocorticoid levels in camel hair using competitive ELISA - Comparison with LC-MS/MS.
    Ashraf SS; El-Gahany W; Alraeesi A; Al-Hajj L; Al-Maidalli A; Shah I
    Drug Test Anal; 2020 Apr; 12(4):458-464. PubMed ID: 31840435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging drugs--potential for misuse in sport and doping control detection strategies.
    Thevis M; Schänzer W
    Mini Rev Med Chem; 2007 May; 7(5):531-7. PubMed ID: 17504189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigations into the analysis of intact drug conjugates in animal sport doping control - Development and assessment of a rapid and economical approach for screening greyhound urine.
    Gray B; Tuckley L; Cutler C; Biddle S; Hudson S; Gower S; Vanhaecke L
    Drug Test Anal; 2020 Jun; 12(6):731-742. PubMed ID: 32052913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
    Ashenden M; Gough CE; Garnham A; Gore CJ; Sharpe K
    Eur J Appl Physiol; 2011 Sep; 111(9):2307-14. PubMed ID: 21336951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM; Mansour MM
    Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes.
    Knoop A; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2019 Feb; 33(4):371-380. PubMed ID: 30394592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strengths and weaknesses of established indirect models to detect recombinant human erythropoietin abuse on blood samples collected 48-hr post administration.
    Connes P; Caillaud C; Simar D; Villard S; Sicart MT; Audran M
    Haematologica; 2004 Jul; 89(7):891-2. PubMed ID: 15257956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening and confirmation of recombinant human follistatin in equine plasma for doping control purposes.
    Wong KS; Cheung HW; Choi YC; To NS; Wan TSM; Ho ENM
    Drug Test Anal; 2024 Mar; 16(3):259-267. PubMed ID: 37401514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mass spectrometric detection of peginesatide in human urine in doping control analysis.
    Möller I; Thomas A; Delahaut P; Geyer H; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2012 Nov; 70():512-7. PubMed ID: 22884786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
    Pitsiladis YP; Durussel J; Rabin O
    Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a flunixin metabolite in camel by gas chromatography-mass spectrometry.
    Wasfi IA; Hadi AA; Alkatheeri NA; Barezaiq IM; ElGhazali M; Boni NS; Zorob O
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):209-15. PubMed ID: 9657217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative analysis of images in erythropoietin doping control.
    Bajla I; Holländer I; Gmeiner G; Reichel Ch
    Med Biol Eng Comput; 2005 May; 43(3):403-9. PubMed ID: 16035230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythropoietin test methods.
    Breymann C
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):135-45. PubMed ID: 10932816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.